Trials / Conditions / Comparative Bioavailability
Comparative Bioavailability
5 registered clinical trials studyying Comparative Bioavailability.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration NCT04790136 | SocraTec R&D GmbH | Phase 1 |
| Completed | S-flurbiprofen Bioavailability Trial to Compare a Newly Developed Patch vs. a Marketed Tablet NCT04505787 | SocraTec R&D GmbH | Phase 1 |
| Withdrawn | Bioequivalence Study of Gliclazide 120 mg Modified Release Tablets NCT02980757 | Disphar International B.V. | Phase 1 |
| Completed | A Marketing-oriented Study to Evaluate the Comparative Bioavailability of Omega-3 Fatty Acids From Four Differ NCT01960660 | Nordic Pharma, USA | N/A |
| Withdrawn | Comparative Bioavailability Study of Metformin HCl 1000 mg Granules vs Glucophage 1000 mg Film-coated Tablet NCT02217670 | Disphar International B.V. | Phase 1 |